These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1829223)

  • 21. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC; Derrington E; Aguera M; Belin MF
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):270-8. PubMed ID: 8795598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on paraneoplastic syndromes.
    Dropcho EJ
    Curr Opin Neurol; 2005 Jun; 18(3):331-6. PubMed ID: 15891421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of the detection of anti-nervous system autoantibodies in neurologic paraneoplastic syndromes].
    Honnorat J; Antoine JC
    Rev Med Interne; 1994 Feb; 15(2):124-33. PubMed ID: 8059119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W; Drlicek M; Liszka U
    Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paraneoplastic neurological syndromes].
    Lambert N; Lutteri L; Sadzot B; Maquet P; Moonen G
    Rev Med Liege; 2021 May; 76(5-6):413-418. PubMed ID: 34080373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic neurological syndrome: diagnosis and therapy].
    Inuzuka T
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1365-6. PubMed ID: 9128413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmune mechanisms in the pathogenesis of neurologic paraneoplastic diseases].
    Pelikán F; Timová S
    Bratisl Lek Listy; 1997 Jun; 98(6):335-8. PubMed ID: 9333425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunological diagnosis of paraneoplastic neurologic syndromes].
    Carpentier AF; Delattre JY
    Presse Med; 1996 Nov; 25(37):1835-8. PubMed ID: 8991038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology of paraneoplastic syndromes: overview.
    Posner JB
    Ann N Y Acad Sci; 2003 Sep; 998():178-86. PubMed ID: 14592873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient.
    Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S
    Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Paraneoplastic subacute sensory Denny-Brown neuronopathy or anti-Hu syndrome: a classical paraneoplastic syndrome].
    Lövblad KO; Boucraut J; Steck AJ
    Rev Med Suisse Romande; 1995 May; 115(5):421-6. PubMed ID: 7770690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiology of paraneoplastic neurological syndromes.
    Liblau R; Benyahia B; Delattre JY
    Ann Med Interne (Paris); 1998 Dec; 149(8):512-20. PubMed ID: 10021905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The paraneoplastic syndrome from the neurologic viewpoint].
    Neundörfer B
    Fortschr Med; 1981 Dec; 99(45):1871-6. PubMed ID: 7308955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraneoplastic syndromes affecting the nervous system.
    Dalmau JO; Posner JB
    Semin Oncol; 1997 Jun; 24(3):318-28. PubMed ID: 9208887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advances in paraneoplastic encephalomyeloneuronopathy].
    Sakai K
    Nihon Rinsho; 1994 Nov; 52(11):3006-12. PubMed ID: 7996702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.